PRESS RELEASE

SVAS BIOSANA PUBLISHES

ITS FINANCIAL CALENDAR FOR 2022

Somma Vesuviana (Naples) 28 January 2022 - Svas Biosana S.p.A., (the "Company" or "SVAS"), a leading player in the production and distribution of medical devices for public and private healthcare facilities, and listed on Euronext Growth Milan, a multilateral trading system organised and managed by Borsa Italiana S.p.A. which focuses on small and medium-sized companies with high growth potential, publishes its financial calendar for 2022 in accordance with the disclosure requirements set out in article 17 of Euronext Growth Milan's Issuer Regulation. The calendar was approved by the Board of directors.

DATE

EVENT

14 April 2022

Meeting of the Board of directors to approve the draft

financial statements as at and for the year ended 31

December 2021

16 May 2022

Ordinary Shareholders' Meeting to approve the financial

statements as at and for the year ended 31 December 2021

26 September 2022

Meeting of the Board of directors to approve the interim

financial report as at and for the six months ending 30 June

2022, subject to review by the independent auditors

The above dates may be subject to change, always in compliance with the terms provided for by applicable laws and regulations. Should this be the case, Svas Biosana S.p.A. will promptly inform the market.

* * * * * *

The financial calendar is available on the Company's website at the following address: https://svas.it/investor-relations/calendario-finanziario/.

This press release can be found at Borsa Italiana, at the Company's registered office, and in the Investor Relations/Financial Press Releases section of the website www.svas.it. Svas Biosana uses the eMarket SDIR system, managed by Spafid Connect S.p.A., with registered office at Foro Buonaparte 10, Milan (www.emarketstorage.com), to disclose regulated information.

* * * * * * * *

SVAS BIOSANA S.p.A.

Registered Office

Correspondence

Headquarters and Offices

Contacts

Companies Register of

Via M. Perillo, 34

Post Box 91

Via Trentola, 7

Tel. +390818995411

Naples no. 4543/85

80047

80049

80049

Fax +390818993922

R.E.A. no. 393065

San Giuseppe Vesuviano (NA)

Somma Vesuviana (NA)

Somma Vesuviana (NA)

www.svas.it

Tax Code 04720630633

Italy

Italy

Italy

svasbiosana@legalmail.it

VAT no. 01354901215

Contacts:

SVAS Biosana S.p.A.

Euronext Growth Advisor

Andrea Efficace

Banca Profilo

CFO Group and Investor Relations Manager

Via Cerva 128, Milan

+39 081.8995411

+39 02.584081

a.efficace@svas.it

alessio muretti@bancaprofilo.it

Investor Relations Advisor

Media Relations Advisor

POLYTEMS HIR

POLYTEMS HIR

Bianca FERSINI MASTELLONI - Silvia MARONGIU

Paolo SANTAGOSTINO

+06.69923324-066797849

+393493856585

s.marongiu@polytemshir.it

p.santagostino@polytemshir.it

Specialist

Banca Profilo

+39 02.584081

Svas Biosana manufactures and distributes medical devices in Italy and abroad. Founded in 1972 in Somma Vesuviana (NA) by the Perillo family, SVAS is now an international company with a catalogue of approximately 16,000 own and third-party brand products, roughly 370 employees, a Research and Development department, 3 production facilities in Italy and subsidiaries in Slovenia, Croatia, Serbia and Bosnia- Herzegovina.

Ticker: ISIN Ordinary Shares: IT0005469264 Ticker: ISIN Warrant SVAS BIOSANA 2021-2024: IT0005469157

SVAS BIOSANA S.p.A.

Registered Office

Correspondence

Headquarters and Offices

Contacts

Companies Register of

Via M. Perillo, 34

Post Box 91

Via Trentola, 7

Tel. +390818995411

Naples no. 4543/85

80047

80049

80049

Fax +390818993922

R.E.A. no. 393065

San Giuseppe Vesuviano (NA)

Somma Vesuviana (NA)

Somma Vesuviana (NA)

www.svas.it

Tax Code 04720630633

Italy

Italy

Italy

svasbiosana@legalmail.it

VAT no. 01354901215

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Svas Biosana S.p.A. published this content on 28 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 January 2022 16:52:07 UTC.